E Fund Management Co. Ltd. Boosts Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO)

E Fund Management Co. Ltd. raised its stake in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 41.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 13,152 shares of the biopharmaceutical company’s stock after acquiring an additional 3,875 shares during the […]

Related Keywords

United States ,Belgium ,Switzerland ,Ireland ,Japan ,Piper Sandler ,Michaelj Labarre ,Vanguard Group Inc ,Nasdaq ,Fund Management Co ,Exchange Commission ,E Fund Management Co ,Artisan Partners Limited Partnership ,Geode Capital Management ,Macquarie Group Ltd ,Halozyme Therapeutics Inc ,Morgan Stanley ,Halozyme Therapeutics ,Free Report ,Fund Management ,Partners Limited Partnership ,Capital Management ,Visit Holdingschannel ,Halozyme Therapeutics Daily ,Nasdaq Halo ,Halo ,Medical ,40637h10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,